Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Company news
>
2015
Company news, 2015
2015 Chinese Medicinal Chemistry Symposium(CMCS2015) 5th CPA-RSC Symposium on Medicinal Chemistry in August
CMCS & China-UK JSMC) is one of the most influential events in the field of Medicinal chemistry in China.
IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
WILMINGTON, Del.
1
